Polyrizon (PLRZ) Other Non-Current Assets (2025)

Polyrizon's (PLRZ) quarterly Other Non-Current Assets came in at $6.0 million in Q4 2025.

Polyrizon (PLRZ) Other Non-Current Assets (2025) Analysis & Trends

Polyrizon (PLRZ) has 1 years of Other Non-Current Assets data on file, last reported at $6.0 million in Q4 2025.

Quarterly Other Non-Current Assets changed N/A year-over-year to $6.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.0 million (changed N/A YoY) and the FY2025 annual result came in at $6.0 million, changed N/A from the prior year.
Other Non-Current Assets steadied at $6.0 million in Q4 2025.
In the past five years, Other Non-Current Assets ranged from a high of $6.0 million in Q4 2025 to a low of $6.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.25 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	2.31 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	124.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	618.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	109.58 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	65.13 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	202.31 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	104.44 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	62.96 Mn
10	Polyrizon	7.27 Mn	-4.22 Mn	-	6.02 Mn

Download Data

Date	Value
Dec 31, 2025	6.02 Mn